articleUCL Discovery (University College London)Jun 7, 2007Closed access

Natural history and outcome in systemic AA amyloidosis

LHLachmann, HJGHGoodman, HJBGJGilbertson, JAGJGallimore, JRSCSabin, CA

Amyloidosis Foundation · The Royal Free Hospital · +1 more institution

Abstract

BACKGROUND:Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes systemic AA amyloidosis, a serious complication of many chronic inflammatory disorders. Little is known about the natural history of AA amyloidosis or its response to treatment.METHODS:We evaluated clinical features, organ function, and survival among 374 patients with AA amyloidosis who were followed for a median of 86 months. The SAA concentration was measured serially, and the amyloid burden was estimated with the use of whole-body serum amyloid P component scintigraphy. Therapy for inflammatory diseases was administered to suppress the production of SAA.RESULTS:Median survival after…

Citation impact

781
total citations
FWCI
16.54
Percentile
100%
References
21
Citations per year

Authors

7
  • LH
    Lachmann, HJCorresponding

    Amyloidosis Foundation

  • GH
    Goodman, HJB

    Amyloidosis Foundation

  • GJ
    Gilbertson, JA

    Amyloidosis Foundation

  • GJ
    Gallimore, JR

    Amyloidosis Foundation

  • SC
    Sabin, CA

    The Royal Free Hospital, University College London

Topics & keywords

Keywords
  • Amyloidosis
  • Medicine
  • AA amyloidosis
  • Amyloid (mycology)
  • Serum amyloid A
  • Serum Amyloid A Protein
  • Natural history
  • Complication
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.